99616-64-5

Basic information

• Product Name: 1-(2-hydroxyethyl)-2-methyl-5-nitroimidazole N-(5-carboxy-5-aminopentane)carbamate
• Synonyms: 1-(2-hydroxyethyl)-2-methyl-5-nitroimidazole N-(5-carboxy-5-aminopentane)carbamate
• CAS NO: 99616-64-5
• Molecular Formula: C6H9N3O3
• Molecular Weight: 171.154
• Mol File: 99616-64-5.mol
• Article Data: 0

Chemical Properties

• Boiling Point: 405.4 °C at 760 mmHg
• Flash Point: 199 °C
• Appearance: /
• Density: 1.45 g/cm³
• CAS DataBase Reference: 1-(2-hydroxyethyl)-2-methyl-5-nitroimidazole N-(5-carboxy-5-aminopentane)carbamate(CAS DataBase Reference)
• NIST Chemistry Reference: 1-(2-hydroxyethyl)-2-methyl-5-nitroimidazole N-(5-carboxy-5-aminopentane)carbamate(99616-64-5)
• EPA Substance Registry System: 1-(2-hydroxyethyl)-2-methyl-5-nitroimidazole N-(5-carboxy-5-aminopentane)carbamate(99616-64-5)

Safety Data

• Hazardous Substances Data: 99616-64-5(Hazardous Substances Data)

Usage

Chemical structure

1-(2-hydroxyethyl)-2-methyl-5-nitroimidazole N-(5-carboxy-5-aminopentane)carbamate is a complex organic compound with a nitroimidazole ring and a carboxy-aminopentane group.

Functional groups

The compound contains a nitroimidazole ring, which is known for its antibacterial and antiparasitic properties, and a carboxy-aminopentane group, which may target bacterial or parasitic cell membranes.

Potential applications

The compound has potential pharmaceutical applications due to its antibacterial and antiparasitic properties.

Synergistic effects

The dual functional groups of the compound may offer synergistic effects in inhibiting bacterial or parasitic growth.

Research potential

Further research into the biological and pharmacological properties of the compound could lead to the development of new drugs for the treatment of infectious diseases.

Chemical properties

The compound's chemical properties, such as solubility, stability, and reactivity, would need to be further investigated to determine its suitability for pharmaceutical applications.

Safety and toxicity

The safety and toxicity of the compound would need to be evaluated to ensure that it is safe for use in humans and does not have any adverse side effects.

Synthesis

The synthesis of the compound would need to be optimized to ensure that it can be produced efficiently and cost-effectively on a large scale.

Drug delivery

The compound's drug delivery methods, such as oral, topical, or intravenous administration, would need to be determined to maximize its effectiveness and minimize any potential side effects.

Clinical trials

If the compound shows promise in preclinical studies, it would need to undergo clinical trials to evaluate its safety and efficacy in humans before it can be approved for use as a pharmaceutical drug.